Derin B. Keskin, Ph.D.
Affiliations: | 2002 | Medical College of Georgia, Augusta, GA, United States |
Area:
Immunology, Cell BiologyGoogle:
"Derin Keskin"Parents
Sign in to add mentor| Andrew L. Mellor | grad student | 2002 | Medical College of Georgia | |
| (Regulation of T cell immunity by cells expressing indoleamine 2,3 -dioxygenase.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bae J, Kitayama S, Herbert Z, et al. (2023) Differentiation of BCMA-specific induced pluripotent stem cells into CD8αβ+ T cells targeting multiple myeloma. Blood |
| Truex NL, Mohapatra S, Melo M, et al. (2023) Design of Cytotoxic T Cell Epitopes by Machine Learning of Human Degrons. Biorxiv : the Preprint Server For Biology |
| Mota I, Patrucco E, Mastini C, et al. (2023) ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer. Nature Cancer |
| Lee PC, Klaeger S, Le PM, et al. (2022) Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma. The Journal of Clinical Investigation. 132 |
| Oliveira G, Stromhaug K, Cieri N, et al. (2022) Landscape of helper and regulatory antitumour CD4 T cells in melanoma. Nature |
| Bachireddy P, Azizi E, Burdziak C, et al. (2021) Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy. Cell Reports. 37: 109992 |
| Oliveira G, Stromhaug K, Klaeger S, et al. (2021) Phenotype, specificity and avidity of antitumour CD8 T cells in melanoma. Nature |
| Weingarten-Gabbay S, Klaeger S, Sarkizova S, et al. (2021) Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell |
| Zhang G, Chitkushev L, Olsen LR, et al. (2021) TANTIGEN 2.0: a knowledge base of tumor T cell antigens and epitopes. Bmc Bioinformatics. 22: 40 |
| Braun DA, Street K, Burke KP, et al. (2021) Progressive immune dysfunction with advancing disease stage in renal cell carcinoma. Cancer Cell |